SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
April 1, 1998
------------------------------------------------------
Date of Report (Date of earliest event reported)
INHALE THERAPEUTIC SYSTEMS
------------------------------------------------------
(Exact name of registrant as specified in its charter)
California 023556 94-3134940
- ---------------------- ---------------- ------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
150 Industrial Road
San Carlos, CA 94070
----------------------------------------
(Address of principal executive offices)
(650) 631-3100
----------------------------------------------------
(Registrant's telephone number, including area code)
1.
ITEM 5. OTHER EVENTS
On April 1, 1998, Inhale Therapeutic Systems announced the completion of
a re-negotiation of its collaborative agreement with Baxter International,
Inc. A press release relating to the re-negotiation is attached hereto as
Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibits
99.1 Press Release dated April 1, 1998
2.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INHALE THERAPEUTIC SYSTEMS
Dated: April 7, 1998 By: /s/ Robert B. Chess
-------------------------------------
Robert B. Chess
President and Chief Executive Officer
3.